Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Supaglutide

A Study of Supaglutide in Chinese Type 2 Diabetes Patients

Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2 · Completed · Enrollment 40

NCT04314622

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.